Oculis

Industry · 8 registered clinical trials.

Status	Trial	Phase	Started
Active Not Recruiting	A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2 Diabetic Macular Edema	Phase 3	2024-03-15
Terminated	Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery Inflammation Eye, Pain, Postoperative, Cataract	Phase 3	2023-12-18
Completed	Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease Dry Eye Disease	Phase 2	2023-11-29
Completed	A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Inflammation Eye Pain, Postoperative Cataract	Phase 3	2022-06-24
Active Not Recruiting	A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1 Diabetic Macular Edema	Phase 2 / Phase 3	2021-10-19
Completed	OCS-05 in Patients With Optic Neuritis Optic Neuritis	Phase 2	2021-02-10
Completed	OCS-01 in Treating Inflammation and Pain in Post-cataract Patients Inflammation Corneal, Pain, Postoperative	Phase 2	2019-09-27
Completed	Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema Diabetic Macular Edema	Phase 2	2017-09-18